BURLINGTON, Mass. and PLANO, Texas, U.S. — Keurig Dr Pepper announced on November 19, 2020, the completion of its previously-announced registered public secondary offering of 60 million shares of the Company’s outstanding common stock, for gross proceeds to the selling stockholders of approximately $1.7 billion. Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC are acting as the underwriters for the offering.
The offering was made only by means of an effective registration statement and a prospectus. Copies of the prospectus supplement and the accompanying prospectus relating to the offering may be obtained from: Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, New York 10282, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing Prospectus-ny@ny.email.gs.com. Morgan Stanley & Co. LLC at 180 Varick Street, 2nd Floor, New York, New York 10014, Attention: Prospectus Department.
Copies of the prospectus supplement and the related prospectus may also be obtained free of charge from the website of the U.S. Securities and Exchange Commission (the “SEC”) at http://www.sec.gov.
Keurig Dr Pepper has previously filed with the SEC a registration statement (including a prospectus) on Form S-3 (File No. 333-233477) and a prospectus supplement, each dated August 27, 2019, as well as a final prospectus supplement for the offering to which this communication relates.
Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering.
Copies of the registration statement can be accessed through the SEC’s website at www.sec.gov. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
